Link Cell Therapies - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeLink Cell Therapies
Link Cell Therapies logo

Link Cell Therapies

0 followers

About Link Cell Therapies

Link Cell Therapies is a biotechnology company focused on developing precise CAR T cell therapies for cancer. Founded by Stanford researchers and backed by Samsara BioCapital, the company aims to safely deploy CAR T beyond current indications using a true AND-gate logic to require co-expression of cancer targets for tumor-specific cytotoxicity. Their programs target solid tumors and select hematologic cancers, with multiple platforms under development to expand the potential of CAR T therapies. Based in the San Francisco Bay Area, the company emphasizes translational immunotherapy research and

Recent News

Recent Deals

Key Team Members

Jerry Cacia

Chief Operating Officer

Mark Wallet, Ph.D.

Chief Scientific Officer

Alex Bankovich, Ph.D.

Vice President of Preclinical R&D

Diego Vargas, Ph.D.

Vice President of Cell Therapy

Angeles Estellés, Ph.D.

Director, Protein Sciences

Key Facts

HQ Location

South San Francisco, United States

Founded

2022

Employees

11 - 50

Status

Private

Website

https://linkcelltx.com